Sequenom, Inc.

Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix

Role: lead

Non-Invasive Preeclampsia Screening and Biobank

Role: lead

The Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid Arthritis

Role: lead

Evaluation of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit

Role: lead

Compliant Analysis of Patient Samples and Data

Role: lead

Clinical Follow-up of Pregnant Subjects Undergoing NIPT

Role: lead

Specimen Collection from Patients with Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay

Role: lead

Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy

Role: lead

Development of a NIPTT for Detecting Copy Number Variations

Role: lead

Impact of Guided Care With the Vectra Multi-biomarker Disease Activity (MBDA) Blood Test

Role: lead

Noninvasive Screening for Affected Pregnancies: Assay Development & Optimization in Affected Pregnancies

Role: lead

Molecular Stethoscope

Role: collaborator

Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies

Role: lead

Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies

Role: lead

Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD

Role: lead

Clinical Performance of the MaterniT21 PLUS LDT in Multiple Gestation Pregnancies

Role: lead

A New Prenatal Blood Test for Down Syndrome

Role: collaborator

Association of Macular Pigment Optical Density (MPOD) and Genetic Variants in Complement Factor H in Subjects With Choroidal Neovascular (CNV)

Role: lead

Determination of Performance Characteristics of the MassPLEX Factor II/V Leiden Test

Role: lead

Genetic Load and Phenotype in Aggressive AMD

Role: lead